Seven Proposed Cancellations of Health Food Functions! A Brief Discussion on the Development of Health Foods
On January 13, the State Administration for Market Regulation issued a public consultation on the "Announcement on the Release of the Directory of Health Functions Allowed for Health Food Claims for Non-Nutrient Supplements and Supporting Documents".
July 2, 2024
by Xiaomichong
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
January 2, 2024
by Shruti Talashi
ProBioGen’s Growth Strategy Continues Successfully
In line with this growth, three crucial positions have been filled. These appointments reflect the company's commitment to continued growth.
March 6, 2023
by PharmaSources
Cidara and Mundipharma sign rezafungin drug development deal
US-based biotech Cidara Therapeutics has partnered with UK-based Mundipharma in a deal valued at more than $568m to develop and commercialise its anti-fungal drug rezafungin.
September 5, 2019
by pharmaceutical-technology
Provention Bio Appoints Clinical Development SVP
Dr. Kell will lead the PRV-031 program, including the oversight of the Phase III PROTECT study and support of regulatory submissions.
August 21, 2019
by contractpharma
Boehringer Ingelheim, MD Anderson Form Virtual Cancer R&D Center
New potential gastrointestinal and lung cancer therapies from Boehringer’s pipeline will be combined with MD’s drug development capabilities.
August 13, 2019
by contractpharma
Oric closes funding to develop glucocorticoid antagonist ORIC-101
Oric Pharmaceuticals has closed a Series D financing to support the continued development of a clinical-stage, selective and potent glucocorticoid receptor antagonist, ORIC-101.
August 12, 2019
by pharmaceutical-technology
Sensyne Health and Bayer partner on AI drug development
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical company Bayer to accelerate the development of new heart therapies.
August 5, 2019
by pharmaceutical-technology
MilliporeSigma Launches Plug & Play Upstream Development Service
Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-ups.
August 2, 2019
by contractpharma
Mereo BioPharma Appoints Head of Pharma Development
Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations.
July 17, 2019
by contractpharma
Digital design for pharmaceutical product and process development
Digital design for pharmaceutical product and process development.
July 5, 2019
by europeanpharmaceuticalreview
Asieris, Photocure Enter into License Agreement for Cevira Development
Asieris MediTech and Photocure announced they have entered into a License Agreement for world-wide development and commercialization of Cevira® for the treatment of HPV induced cervical precancerous lesions.
July 3, 2019
by americanpharmaceuticalreview